Global Mycobacterium Tuberculosis Antibodies Market Insights, Forecast to 2028

Market Analysis and Insights: Global Mycobacterium Tuberculosis Antibodies Market
Due to the COVID-19 pandemic, the global Mycobacterium Tuberculosis Antibodies market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Monoclonal accounting for % of the Mycobacterium Tuberculosis Antibodies global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals & Diagnostic Laboratories segment is altered to an % CAGR throughout this forecast period.
China Mycobacterium Tuberculosis Antibodies market size is valued at US$ million in 2021, while the US and Europe Mycobacterium Tuberculosis Antibodies are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Mycobacterium Tuberculosis Antibodies landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Mycobacterium Tuberculosis Antibodies include Abbexa Ltd, Abcam, Abnova Corporation, Absolute Antibody, Antibodies-online, BIOCARE MEDICAL, Bio-Rad, Biorbyt and Bioss Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Mycobacterium Tuberculosis Antibodies Scope and Segment
Mycobacterium Tuberculosis Antibodies market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Mycobacterium Tuberculosis Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology
Research Institutes
Others
By Company
Abbexa Ltd
Abcam
Abnova Corporation
Absolute Antibody
Antibodies-online
BIOCARE MEDICAL
Bio-Rad
Biorbyt
Bioss Inc.
CEDARLANE
Creative Biolabs
EastCoast Bio
Fitzgerald Industries International
GeneTex
HyTest Ltd.
LifeSpan BioSciences
MyBioSource.com
Novus Biologicals
OriGene Technologies
ProSci, Inc
QED Bioscience Inc.
Santa Cruz Biotechnology, Inc.
Thermo Fisher Scientific
United States Biological
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE